KW-2450

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameKW-2450
Drug Alias NameKW-2450
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin receptor inhibitorsInsulin-like growth factor I receptor antagonists
TargetsInsulin-like growth factor I receptorInsulin receptor
Therapy Area/IndicationsSolid tumoursBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Hakko Kirin Pharma IncKyowa Kirin Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A